The University of Chicago Header Logo

Connection

Peter Sand to Central Nervous System

Back to Details
This is a "connection" page, showing publications Peter Sand has written about Central Nervous System.
Peter Sand
Connection Strength
0.061
Central Nervous System
  1. Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol. 2005 Jun; 192(6):1849-54; discussion 1854-5.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.